ReviewCurrent urology2023

Enfortumab vedotin and pembrolizumab as monotherapies and combination treatment in locally advanced or metastatic urothelial carcinoma: A narrative review.

Maria A Bantounou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.